Arbutus Biopharma
2 followers
Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).
Org chart
Michael McElhaugh
Collapse
David C. Hastings
Chief Financial Officer
Elizabeth Howard
EVP, General Counsel & Chief Compliance Officer
Michael J. Sofia Phd
Chief Scientific Officer
Karen Sims
Chief Medical Officer
Catherine Coffey Ross
Vice President Commercial Development
Michael Child
Vice President Clinical Operations
Shannon Briscoe
Vice President Human Resources
Ganapati Reddy Pamulapati
Senior Vice President, Pharmaceutical Development And Manufacturing
Similar companies
Adverum Biotech
8 followers
REVOLUTION Medicines
5 followers
Dyne Therapeutics
3 followers
Cidara Therapeutics
1 follower
Abeona Therapeutics
1 follower
Verastem
1 follower
Thermo Fisher Scientific
141 followers
Genentech
142 followers
Gilead Sciences
119 followers
Vertex Pharmaceuticals
50 followers
Ionis Pharmaceuticals
22 followers
Discover companies